Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?
BACKGROUND Complete gross resection (CGR) a key determinant of survival in advanced ovarian cancer (AOC). Preoperative imaging is used to predict residual disease (RD) and surgical complexity in the primary setting, but its performance after neoadjuvant chemotherapy (NACT) remains unclear. We evaluated the ability of c...